FindTrial
Sign In

Clinical study of ERAS strategy in perioperative period of POEM patients

Clinical study of ERAS strategy in perioperative period of POEM patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012905
Enrollment
Unknown
Registered
2017-10-08
Start date
2017-10-15
Completion date
Unknown
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal achalasia

Interventions

ERAS group:ERAS strategy
Control group:Traditional approach

Sponsors

Zhongshan hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Achalasia patients undergoing peroral endoscopic myotomy; 2) American Society of Anesthesiologists (ASA) physical status I-II, 18-75 years of age.

Exclusion criteria

Exclusion criteria: 1) Preoperative high temperature, increasing white blood cell count (such as the recent fever, infection); 2) End-stage tumor with multiple metastases or combined with other tumors; 3) Allergy to dizocine or parecoxib.

Design outcomes

Primary

MeasureTime frame
Length of standard hospital stay;Qor-40 questionnaire;—

Secondary

MeasureTime frame
postoperative complication;—

Countries

China

Contacts

Public ContactShengjin Ge

Zhongshan hospital of Fudan University

varying@126.com+86 13601926171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026